An urgent recall has been issued for a common blood pressure drugs over fears of cancer-causing chemicals.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued a notice concerning 25 batches of Irbesartan-containing medicinal products.
The precautionary measure has been circulated to pharmacies and wholesalers - reports Birmingham Live.
READ MORE: HMRC issues update for everyone who's claimed any SEISS grant
So that means patients are being instructed not to check their own packs of tablets.
Irbesartan is mostly used for treating high blood pressure but can also be used among some kidney patients.
Dr Alison Cave, MHRA chief safety officer, said: "Patient safety is at the heart of what we do.
"We're recalling batches of certain sartan-containing products as a precautionary measure while we continue our investigation.
"It's important that healthcare professionals check their stock to quarantine and return these batches.
"If you've been taking one of the affected products, continue to take your medication."
In her statement, Dr Cave then added: "Speak with your doctor or pharmacist before stopping any treatment, they can address any concerns and can advise you on the best course of action.
"Previous recalls of these types of products in 2018, 2019 and June 2021 are part of an ongoing investigation.
" The MHRA is working with other medicines regulators on this issue."
Experts stressed that people should not abruptly stop taking their medication without consulting a pharmacist or doctor first.
Receive newsletters with the latest news, sport and what's on updates from the Liverpool ECHO by signing up here
